产品编号 :
Cas No. :
| 包装规格 | 纯度 | 目录价 | 会员专享价 | 库存 | 数量 |
|---|---|---|---|---|---|
| 1mg | 98% | 询价 | |||
| 5mg | 98% | 询价 | |||
| 10mg | 98% | 询价 | |||
| 50mg | 98% | 询价 | |||
| 100mg | 98% | 询价 | |||
| 250mg | 98% | 询价 | |||
| 1g | 98% | 询价 |
| 包装规格 | 纯度 | 目录价 | 会员专享价 | 库存 | 数量 |
|---|---|---|---|---|---|
| 1mg | 98% | 询价 | |||
| 5mg | 98% | 询价 | |||
| 10mg | 98% | 询价 | |||
| 50mg | 98% | 询价 | |||
| 100mg | 98% | 询价 | |||
| 250mg | 98% | 询价 | |||
| 1g | 98% | 询价 |
CAS No. |
950769-58-1 |
|---|---|
中文名称 |
1-(5-(叔丁基)异噁唑-3-基)-3-(4-(7-(2-吗啉乙氧基)苯并[d]咪唑并[2,1-b]噻唑-2-基)苯基)脲 |
英文名称 |
1-(5-(tert-Butyl)isoxazol-3-yl)-3-(4-(7-(2-morpholinoethoxy)benzo[d]imidazo[2,1-b]thiazol-2-yl)phenyl)urea |
别名 |
NCGC00242493-02 | N-(5-tert-Butylisoxazol-3-yl)-N'-[4-[7-[2-(morpholin-4-yl)ethoxy]imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl]urea | NCI60_041312 | quizartinibum | AC220 | AC-220 | SMR004703000 | vanflyta | SCHEMBL72923 | CVWXJKQAOSCOAB-UHFFFAOYSA-N | Ur |
标准英文名 |
1-(5-(tert-butyl)isoxazol-3-yl)-3-(4-(7-(2-morpholinoethoxy)benzo[d]imidazo[2,1-b]thiazol-2-yl)phenyl)urea |
MDL No. |
MFCD18074524 |
分子式 |
C29H32N6O4S |
分子量 |
560.68 |
精确分子量 |
560.22 |
SMILES |
O=C(NC1=CC=C(C2=CN3C(SC4=CC(OCCN5CCOCC5)=CC=C34)=N2)C=C1)NC6=NOC(C(C)(C)C)=C6 |
标准SMILES |
CC(C)(C)C1=CC(NC(=O)NC2C=CC(=CC=2)C2=CN3C(=N2)SC2=CC(=CC=C32)OCCN2CCOCC2)=NO1 |
性状 |
White to Yellow Solid |
用途 |
For laboratory research purposes. Not for drug or household use. |
信号词 |
Warning |
InChIKey |
CVWXJKQAOSCOAB-UHFFFAOYSA-N |
危险类别(旧) |
H302,H315,H319,H335 |
存储要求 |
Sealed in dry,2-8°C,Keep container tightly closed in a dry and well-ventilated area. Containers which are opened must be carefully resealed and kept upright to prevent leakage. |
危险品分类 |
Acute toxicity, oral (Category 4),Skin corrosion/irritation (Category 2),Serious eye damage/eye irritation (Category 2A),Specific target organ toxicity, single exposure; Respiratory tract irritation (Category 3) |
|---|---|
化学稳定性 |
Stable under recommended storage conditions. |
符号 |
|
|
|
评论 |
|---|